VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Bayesian designs to account for patient heterogeneity in phase II clinical trials.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bayesian designs to account for patient heterogeneity in phase II clinical trials.
Bayesian designs to account for patient heterogeneity in phase II clinical trials. Curr Opin Oncol. 2008 Jul; 20(4):407-11.
View in:
PubMed
subject areas
Clinical Trials, Phase II as Topic
Computer Simulation
Humans
Neoplasms
Research Design
authors with profiles
PETER F THALL